NCT06724068CompletedNot Applicable
The Correlation Between Diabetes, Insulin Resistance and Body Composition
Xuan Song1 site in 1 country515 target enrollmentStarted: December 17, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 515
- Locations
- 1
- Primary Endpoint
- Prevalence of Sarcopenia in Diabetic Patients
Study Overview
Brief Summary
The goal of this retrospective study is to learn about the correlation between diabetes, insulin resistance and body compositions.
The main question[s] it aims to answer are:
- [The difference of body composition between the individuals of insulin resistance and diabetes]
- [The effect of diabetes on body composition]
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Adults aged 18 years and older.
- •Diagnosed with type 2 diabetes mellitus according to recognized diagnostic criteria.
- •Availability of complete body composition data (e.g., DXA measurements).
- •Documented HbA1c levels and other glycemic control data.
- •Continuous medical records available during the study period
Exclusion Criteria
- •Presence of other severe metabolic diseases, such as liver failure or kidney failure.
- •Use of medications affecting muscle mass (e.g., glucocorticoids) for more than three months.
- •History of malignancy or ongoing treatment for cancer.
- •Missing critical research data (e.g., diabetes duration or HbA1c levels).
- •History of surgeries causing significant body composition changes (e.g., bariatric surgery).
Outcomes
Primary Outcomes
Prevalence of Sarcopenia in Diabetic Patients
Time Frame: Retrospective analysis of data collected between2019 and 2022
The proportion of diabetic patients diagnosed with sarcopenia, assessed based on measurements of muscle mass, muscle strength, and physical performance. Sarcopenia will be defined according to AWGS 2019 and EWGSOP2
Secondary Outcomes
No secondary outcomes reported
Investigators
Xuan Song
Principal Investigator
Qianfoshan Hospital
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Insulin Resistance in Atopic Dermatitis PatientsAtopic DermatitisNCT05904509Bezmialem Vakif University32
Completed
Not Applicable
Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin EffectGlucose IntoleranceInsulin ResistanceNCT00784745University Hospital, Gentofte, Copenhagen21
Completed
Not Applicable
Study of Insulin Resistance and Endometrial Cancer in Harris County, TexasEndometrial CancerNCT00495235M.D. Anderson Cancer Center147
Completed
Not Applicable
Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's LipodystrophyLipodystrophyDunnigan SyndromeNCT05424913Centre Hospitalier Universitaire de la Réunion150
Completed
Not Applicable
Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal IrradiationChildhood Cancer Survivors Treated With Abdominal RadiationNCT02248779Memorial Sloan Kettering Cancer Center42